Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Investors

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

Minimum 15 minutes delayed. Source: LSEG

Show all

Latest Results | Q1 2026

  • Earnings Release

Events

17 Mar 2026 3:00 PM EDT
HCW @ Home with Telix Pharmaceuticals
10 Mar 2026 9:30 AM AEDT
ProstACT Global Part 1 Results
04 Mar 2026 4:30 PM EST
Investor Education Event
The Future of Prostate Imaging: What do physicians want?
02 Mar 2026 1:50 PM EST
TD Cowen 46th Annual Health Care Conference
26 Feb 2026 4:40 PM EST
Oppenheimer 36th Annual Healthcare Life Sciences Conference
  • All Events

 

Presentations

ProstACT Global Part 1 Data
  • All Presentations

News

17 Apr 2026
Becoming a substantial holder from CGF
17 Apr 2026
Change in substantial holding
16 Apr 2026
Notification regarding unquoted securities - TLX
16 Apr 2026
Notification of cessation of securities - TLX
15 Apr 2026
Appendix 3B
  • All News Releases

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors